-
Coding References
Learn
Solutions
- Subscription Options
HCPCS Q Code Lookup
HCPCS Q codes cover drugs, biologicals, and related products that CMS codes outside the J range. Biosimilars are the largest group here, billed under the Q5xxx series, which sits alongside cell and gene therapies, skin substitutes, and contrast agents.
Q5126
AlymsysSponsored
- HCPCS Descriptor
- Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
- Manufacturer
- Amneal Biosciences
- Class
- Oncology
- NDCs
- 4
10 mg per unit
View details
Q5169
Armlupeg PFSSponsored
- HCPCS Descriptor
- Injection, pegfilgrastim-unne (armlupeg), biosimilar, 0.5 mg
- Manufacturer
- Valorum Biologics
- Class
- Oncology Colony Stimulating Factor
- NDC
- 1
0.5 mg per unit
View details
Q5146
HERCESSISponsored
- HCPCS Descriptor
- Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg
- Manufacturer
- Accord
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5098
IMULDOSASponsored
- HCPCS Descriptor
- Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg
- Manufacturer
- Accord
- Class
- Immunology
- NDCs
- 3
1 mg per unit
View details
Q5136
JubbontiSponsored
- HCPCS Descriptor
- Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
- Manufacturer
- Sandoz
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q5148
NypoziSponsored
- HCPCS Descriptor
- Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram
- Manufacturer
- Cipla
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 8
1 mcg per unit
View details
Q5166
Osvyrti PFSSponsored
- HCPCS Descriptor
- Injection, denosumab-desu (osvyrti/jubereq), biosimilar, 1 mg
- Manufacturer
- Accord
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q5134
TYRUKOSponsored
- HCPCS Descriptor
- Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
- Manufacturer
- Sandoz
- Class
- Immunology
- NDC
- 1
1 mg per unit
View details
Q5111
UDENYCASponsored
- HCPCS Descriptor
- Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
- Manufacturer
- Accord
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 6
0.5 mg per unit
View details
Q5136
WYOSTSponsored
- HCPCS Descriptor
- Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg
- Manufacturer
- Sandoz
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q2055
Abecma- HCPCS Descriptor
- Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Celgene
- Class
- Oncology
- NDCs
- 3
up to 510 million autologous anti-bcma car-positive viable t cells per unit
View details
Q5145
ABRILADA- HCPCS Descriptor
- Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg
- Manufacturer
- Pfizer
- Class
- Immunology: Anti-TNF
- NDCs
- 4
1 mg per unit
View details
Q4118
ACELL MICROMATRIX 20MG- HCPCS Descriptor
- Matristem micromatrix, 1 mg
- Manufacturer
- Acell
- Class
- Wound Care
- NDCs
- 8
1 mg per unit
View details
Q0249
ACTEMRA- HCPCS Descriptor
- Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Manufacturer
- Multiple Manufacturers
- Class
- COVID-19
- NDCs
- 5
1 mg per unit
View details
Q4159
Affinity- HCPCS Descriptor
- Affinity, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Organogenesis
- Class
- Wound Care
- NDCs
- 2
1 sq cm per unit
View details
Q5150
AHZANTIVE- HCPCS Descriptor
- Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
- Manufacturer
- Formycon AG
- Class
- Ophthalmology
1 mg per unit
View details
Q0180
ANZEMET- HCPCS Descriptor
- Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Manufacturer
- Sanofi
- Class
- Anti-Emetic
- NDCs
- 2
100 mg per unit
View details
Q4101
Apligraf Disk- HCPCS Descriptor
- Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Organogenesis
- Class
- Wound Care
- NDC
- 1
1 sq cm per unit
View details
Q2058
AUCATZYL- HCPCS Descriptor
- Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion
- Manufacturer
- Autolus
- Class
- Oncology
- NDC
- 1
per therapeutic dose per unit
View details
Q5161
Aukelso and Bosaya- HCPCS Descriptor
- Injection, denosumab-kyqq (aukelso/bosaya), biosimilar, 1 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q3027
AVONEX- HCPCS Descriptor
- Injection, interferon beta-1a, 1 mcg for intramuscular use
- Manufacturer
- Biogen
- Class
- Neurology
- NDCs
- 2
1 mcg per unit
View details
Q5121
Avsola- HCPCS Descriptor
- Injection, infliximab-axxq, biosimilar, (avsola), 10 mg
- Manufacturer
- Amgen
- Class
- Immunology: Anti-TNF
- NDCs
- 2
10 mg per unit
View details
Q0237
Avtozma- HCPCS Descriptor
- Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Manufacturer
- Celltrion USA
- Class
- COVID-19
- NDCs
- 3
1 mg per unit
View details
Q5156
AVTOZMA- HCPCS Descriptor
- Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
- Manufacturer
- Multiple Manufacturers
- Class
- Immunology: Anti-TNF
- NDCs
- 5
1 mg per unit
View details
Q4215
AXOLOTL AMBIENT FLOWABLE ALLOGRAFT- HCPCS Descriptor
- Axolotl ambient or axolotl cryo, 0.1 mg
- Manufacturer
- Axolotl Biologix
- Class
- Wound Care
- NDCs
- 3
0.1 mg per unit
View details
Q5162
Bildyos- HCPCS Descriptor
- Injection, denosumab-nxxp (bildyos/bilprevda), biosimilar, 1 mg
- Manufacturer
- Organon
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q4138
BioDDryFlex- HCPCS Descriptor
- Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- BioDLogics LLC
- Class
- Wound Care
- NDCs
- 5
1 sq cm per unit
View details
Q4140
BioDfence Sentry- HCPCS Descriptor
- Biodfence, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- BioDLogics LLC
- Class
- Wound Care
- NDCs
- 15
1 sq cm per unit
View details
Q5152
BKEMV- HCPCS Descriptor
- Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg
- Manufacturer
- Amgen
- Class
- Immunology
- NDC
- 1
2 mg per unit
View details
Q5171
Boncresa PFS- HCPCS Descriptor
- Injection, denosumab-mobz (boncresa), biosimilar, 1 mg
- Manufacturer
- Amneal Biosciences
- Class
- Osteoporosis
- NDC
- 1
1 mg per unit
View details
Q2054
BREYANZI- HCPCS Descriptor
- Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Bristol Myers Squibb
- Class
- Oncology
- NDC
- 1
up to 110 million car-positive viable t cells, per therapeutic dose per unit
View details
Q5124
BYOOVIZ- HCPCS Descriptor
- Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg
- Manufacturer
- Biogen
- Class
- Ophthalmology
- NDCs
- 2
0.1 mg per unit
View details
Q2056
CARVYKTI- HCPCS Descriptor
- Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Janssen
- Class
- Oncology
- NDCs
- 2
up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells per unit
View details
Q2009
CEREBYX- HCPCS Descriptor
- Injection, fosphenytoin, 50 mg phenytoin equivalent
- Manufacturer
- Multiple Manufacturers
- Class
- Neurology
- NDCs
- 16
50 mg pe/ml per unit
View details
Q5128
Cimerli- HCPCS Descriptor
- Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
- Manufacturer
- Coherus Biosciences, Inc
- Class
- Ophthalmology
- NDCs
- 4
0.1 mg per unit
View details
Q5158
CONEXXENCE- HCPCS Descriptor
- Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg
- Manufacturer
- Fresenius Kabi
- Class
- Osteoporosis
- NDCs
- 3
1 mg per unit
View details
Q9961
CONRAY- HCPCS Descriptor
- High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
- Manufacturer
- Guerbet
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 3
1 ml per unit
View details
Q5143
CYLTEZO- HCPCS Descriptor
- Injection, adalimumab-adbm, biosimilar, 1 mg
- Manufacturer
- Boehringer Ingelheim
- Class
- Immunology: Anti-TNF
- NDCs
- 23
1 mg per unit
View details
Q9958
CYSTOGRAFIN- HCPCS Descriptor
- High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
- Manufacturer
- Multiple Manufacturers
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 4
1 ml per unit
View details
Q4166
CYTAL WOUND MATRIX- HCPCS Descriptor
- Cytal, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Multiple Manufacturers
- Class
- Wound Care
- NDCs
- 16
1 sq cm per unit
View details
Q9957
DEFINITY- HCPCS Descriptor
- Injection, perflutren lipid microspheres, per ml
- Manufacturer
- Lantheus Medical Imaging
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 4
1 ml per unit
View details
Q2050
DOXIL- HCPCS Descriptor
- Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
- Manufacturer
- Multiple Manufacturers
- Class
- Oncology
- NDCs
- 30
10 mg per unit
View details
Q0167
DRONABINOL- HCPCS Descriptor
- Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Manufacturer
- Multiple Manufacturers
- Class
- Anti-Emetic
- NDCs
- 12
2.5 mg per unit
View details
Q5167
Enoby- HCPCS Descriptor
- Injection, denosumab-qbde (enoby/xtrenbo), biosimilar, 1 mg
- Manufacturer
- Hikma
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q5149
ENZEEVU- HCPCS Descriptor
- Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg
- Manufacturer
- Sandoz
- Class
- Ophthalmology
1 mg per unit
View details
Q4081
EPOGEN- HCPCS Descriptor
- Injection, epoetin alfa, 100 units (for esrd on dialysis)
- Manufacturer
- Amgen
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 19
100 units per unit
View details
Q5151
EPYSQLI- HCPCS Descriptor
- Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg
- Manufacturer
- Teva
- Class
- Immunology
- NDC
- 1
2 mg per unit
View details
Q5170
Eydenzelt- HCPCS Descriptor
- Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mg
- Class
- Ophthalmology
1 mg per unit
View details
Q0138
FERAHEME- HCPCS Descriptor
- Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
- Manufacturer
- Multiple Manufacturers
- Class
- Anti-Anemia
- NDCs
- 2
1 mg per unit
View details
Q0139
FERAHEME- HCPCS Descriptor
- Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)
- Manufacturer
- Multiple Manufacturers
- Class
- Anti-Anemia
- NDCs
- 2
1 mg per unit
View details
Q5172
Filkri- HCPCS Descriptor
- Injection, filgrastim-laha (filkri), biosimilar, 1 microgram
- Manufacturer
- Accord
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 4
Effective Oct 1, 2026
View details
Q5108
FULPHILA- HCPCS Descriptor
- Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 2
0.5 mg per unit
View details
Q5130
FYLNETRA- HCPCS Descriptor
- Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
- Manufacturer
- Amneal Biosciences
- Class
- Oncology Colony Stimulating Factor
- NDC
- 1
0.5 mg per unit
View details
Q9963
GASTROGRAFIN- HCPCS Descriptor
- High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
- Manufacturer
- Multiple Manufacturers
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 3
1 ml per unit
View details
Q4132
Grafix Core- HCPCS Descriptor
- Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Osiris Therapeutics
- Class
- Wound Care
- NDCs
- 3
1 sq cm per unit
View details
Q0166
Granisetron HCl- HCPCS Descriptor
- Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
- Manufacturer
- Breckenridge
- Class
- Anti-Emetic
- NDCs
- 2
1 mg per unit
View details
Q4164
HELICOLL- HCPCS Descriptor
- Helicoll, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- ENCOLL CORP
- Class
- Wound Care
- NDCs
- 7
1 sq cm per unit
View details
Q5113
HERZUMA- HCPCS Descriptor
- Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg
- Manufacturer
- Teva
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5140
HULIO- HCPCS Descriptor
- Injection, adalimumab-fkjp, biosimilar, 1 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Immunology: Anti-TNF
- NDCs
- 6
1 mg per unit
View details
Q5144
IDACIO- HCPCS Descriptor
- Injection, adalimumab-aacf (idacio), biosimilar, 1 mg
- Manufacturer
- Fresenius Kabi
- Class
- Immunology: Anti-TNF
- NDCs
- 4
1 mg per unit
View details
Q5103
INFLECTRA- HCPCS Descriptor
- Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg
- Manufacturer
- Pfizer
- Class
- Immunology: Anti-TNF
- NDC
- 1
10 mg per unit
View details
Q2038
Influenza Virus Vaccine- HCPCS Descriptor
- Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
- Manufacturer
- Sanofi
- Class
- Vaccine
- NDCs
- 6
per therapeutic dose per unit
View details
Q4104
Integra Bilayer Wound Matrix- HCPCS Descriptor
- Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Integra Lifesciences
- Class
- Wound Care
- NDCs
- 8
1 sq cm per unit
View details
Q4114
Integra Flowable Wound Matrix- HCPCS Descriptor
- Integra flowable wound matrix, injectable, 1 cc
- Manufacturer
- Integra Lifesciences
- Class
- Wound Care
- NDC
- 1
1 cc per unit
View details
Q4105
Integra Omnigraft Dermal Regeneration Matrix- HCPCS Descriptor
- Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Multiple Manufacturers
- Class
- Wound Care
- NDCs
- 11
1 sq cm per unit
View details
Q4108
Integra Wound Matrix- HCPCS Descriptor
- Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Integra Lifesciences
- Class
- Wound Care
- NDCs
- 6
1 sq cm per unit
View details
Q9966
ISOVUE-200- HCPCS Descriptor
- Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
- Manufacturer
- Multiple Manufacturers
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 21
1 ml per unit
View details
Q9967
ISOVUE-300- HCPCS Descriptor
- Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
- Manufacturer
- Multiple Manufacturers
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 114
1 ml per unit
View details
Q5160
JOBEVNE- HCPCS Descriptor
- Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5117
KANJINTI- HCPCS Descriptor
- Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg
- Manufacturer
- Amgen
- Class
- Oncology
- NDCs
- 5
10 mg per unit
View details
Q2042
KYMRIAH- HCPCS Descriptor
- Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Novartis
- Class
- Oncology
- NDCs
- 2
up to 600 million car-positive viable t cells per unit
View details
Q9950
LUMASON- HCPCS Descriptor
- Injection, sulfur hexafluoride lipid microspheres, per ml
- Manufacturer
- Bracco Diagnostics Inc
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 4
1 ml per unit
View details
Q5107
MVASI- HCPCS Descriptor
- Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
- Manufacturer
- Amgen
- Class
- Oncology
- NDCs
- 4
10 mg per unit
View details
Q9983
NEURACEQ- HCPCS Descriptor
- Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- Manufacturer
- Lantheus Medical Imaging
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 2
per study dose, upto 8 mci per unit
View details
Q5110
NIVESTYM- HCPCS Descriptor
- Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
- Manufacturer
- Pfizer
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 6
1 mcg per unit
View details
Q4194
Novachor- HCPCS Descriptor
- Novachor, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Organogenesis, Inc.
- Class
- Wound Care
- NDC
- 1
1 sq cm per unit
View details
Q5168
Nufymco- HCPCS Descriptor
- Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mg
- Manufacturer
- Zydus Pharmaceuticals
- Class
- Ophthalmology
- NDCs
- 2
0.1 mg per unit
View details
Q4160
NuShield- HCPCS Descriptor
- Nushield, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Organogenesis
- Class
- Wound Care
- NDCs
- 9
1 sq cm per unit
View details
Q5122
NYVEPRIA- HCPCS Descriptor
- Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg
- Manufacturer
- Pfizer
- Class
- Oncology Colony Stimulating Factor
- NDC
- 1
0.5 mg per unit
View details
Q4124
OASIS ULTRA TRI-LAYER MATRIX- HCPCS Descriptor
- Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Smith & Nephew
- Class
- Wound Care
- NDCs
- 5
1 sq cm per unit
View details
Q4102
Oasis Wound Matrix Sheet- HCPCS Descriptor
- Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Healthpoint
- Class
- Wound Care
- NDCs
- 2
1 sq cm per unit
View details
Q4103
OASIS WOUND MATRIX SHEET- HCPCS Descriptor
- Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- SMITH & NEPHEW BIOTHERAPEUTICS
- Class
- Wound Care
- NDCs
- 5
1 sq cm per unit
View details
Q5114
OGIVRI- HCPCS Descriptor
- Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Oncology
- NDCs
- 4
10 mg per unit
View details
Q5154
OMLYCLO- HCPCS Descriptor
- Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg
- Manufacturer
- Celltrion USA
- Class
- Immunology
- NDCs
- 3
5 mg per unit
View details
Q9965
OMNIPAQUE- HCPCS Descriptor
- Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
- Manufacturer
- GE Healthcare
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 3
1 ml per unit
View details
Q0162
Ondansetron- HCPCS Descriptor
- Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Manufacturer
- Multiple Manufacturers
- Class
- Anti-Emetic
- NDCs
- 126
1 mg per unit
View details
Q5112
ONTRUZANT- HCPCS Descriptor
- Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg
- Manufacturer
- Organon
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q9956
OPTISON- HCPCS Descriptor
- Injection, octafluoropropane microspheres, per ml
- Manufacturer
- GE Healthcare
- Class
- Imaging/Radiopharmaceutical
- NDCs
- 2
1 ml per unit
View details
Q5153
OPUVIZ- HCPCS Descriptor
- Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg
- Manufacturer
- Biogen Inc.
- Class
- Ophthalmology
1 mg per unit
View details
Q5159
OSPOMYV AND XBRYK- HCPCS Descriptor
- Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg
- Manufacturer
- Cordavis Limited
- Class
- Osteoporosis
- NDC
- 1
1 mg per unit
View details
Q9999
Otulfi- HCPCS Descriptor
- Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg
- Manufacturer
- Fresenius Kabi
- Class
- Immunology
- NDCs
- 6
1 mg per unit
View details
Q5165
Oziltus- HCPCS Descriptor
- Injection, denosumab-mobz (oziltus), biosimilar, 1 mg
- Manufacturer
- Amneal Biosciences
- Class
- Osteoporosis
- NDC
- 1
1 mg per unit
View details
Q5147
PAVBLU- HCPCS Descriptor
- Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg
- Manufacturer
- Amgen
- Class
- Ophthalmology
- NDCs
- 2
1 mg per unit
View details
Q0224
Pemgarda- HCPCS Descriptor
- Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg
- Manufacturer
- Invivyd
- Class
- Anti-Anemia
- NDC
- 1
4500 mg per unit
View details
Q5173
Ponlimsi- HCPCS Descriptor
- Injection, denosumab-adet (ponlimsi), biosimilar, 1 mg
- Class
- Osteoporosis
Effective Oct 1, 2026
View details
Q4110
PriMatrix- HCPCS Descriptor
- Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)
- Manufacturer
- Multiple Manufacturers
- Class
- Wound Care
- NDCs
- 36
1 sq cm per unit
View details
Q0164
PROCHLORPERAZINE MALEATE- HCPCS Descriptor
- Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Manufacturer
- Multiple Manufacturers
- Class
- Psychiatric
- NDCs
- 23
5 mg per unit
View details
Q0169
PROMETHAZINE HCL- HCPCS Descriptor
- Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Manufacturer
- Multiple Manufacturers
- Class
- Antihistamine
- NDCs
- 21
12.5 mg per unit
View details
Q9968
Provayblue- HCPCS Descriptor
- Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
- Manufacturer
- Multiple Manufacturers
- Class
- Misc.
- NDCs
- 4
1 mg per unit
View details
Q2043
PROVENGE- HCPCS Descriptor
- Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
- Manufacturer
- Dendreon Pharmaceuticals
- Class
- Oncology
- NDC
- 1
per infusion (minimum 50 million cells) per unit
View details
Q9996
PYZCHIVA- HCPCS Descriptor
- Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
- Manufacturer
- Cordavis Limited
- Class
- Immunology
- NDCs
- 6
1 mg per unit
View details
Q9997
PYZCHIVA- HCPCS Descriptor
- Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
- Manufacturer
- Quallent Pharmaceuticals
- Class
- Immunology
- NDCs
- 2
1 mg per unit
View details
Q3028
REBIF- HCPCS Descriptor
- Injection, interferon beta-1a, 1 mcg for subcutaneous use
- Manufacturer
- EMD Serono
- Class
- Neurology
- NDCs
- 5
1 mcg per unit
View details
Q5125
RELUKO- HCPCS Descriptor
- Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
- Manufacturer
- Amneal Biosciences
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 4
1 mcg per unit
View details
Q5104
RENFLEXIS- HCPCS Descriptor
- Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
- Manufacturer
- Organon
- Class
- Immunology: Anti-TNF
- NDCs
- 3
10 mg per unit
View details
Q5105
RETACRIT- HCPCS Descriptor
- Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
- Manufacturer
- Vifor International
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 19
100 units per unit
View details
Q5106
RETACRIT- HCPCS Descriptor
- Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
- Manufacturer
- Vifor International
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 15
1000 units per unit
View details
Q5123
RIABNI- HCPCS Descriptor
- Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
- Manufacturer
- Amgen
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5119
RUXIENCE- HCPCS Descriptor
- Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg
- Manufacturer
- Pfizer
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q9998
SELARSDI- HCPCS Descriptor
- Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
- Manufacturer
- Teva
- Class
- Immunology
- NDCs
- 8
1 mg per unit
View details
Q5142
SIMLANDI- HCPCS Descriptor
- Injection, adalimumab-ryvk biosimilar, 1 mg
- Manufacturer
- Teva
- Class
- Immunology: Anti-TNF
- NDCs
- 11
1 mg per unit
View details
Q5164
Starjemza- HCPCS Descriptor
- Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg
- Manufacturer
- Hikma
- Class
- Immunology
- NDCs
- 4
1 mg per unit
View details
Q5099
STEQEYMA- HCPCS Descriptor
- Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg
- Manufacturer
- Celltrion USA
- Class
- Immunology
- NDCs
- 4
1 mg per unit
View details
Q5127
Stimufend- HCPCS Descriptor
- Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg
- Manufacturer
- Fresenius Kabi
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 2
0.5 mg per unit
View details
Q5157
STOBOCLO AND OSENVELT- HCPCS Descriptor
- Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg
- Manufacturer
- Celltrion USA
- Class
- Osteoporosis
- NDCs
- 2
1 mg per unit
View details
Q9991
SUBLOCADE- HCPCS Descriptor
- Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
- Manufacturer
- Indivior
- Class
- Anti-Addiction
- NDCs
- 3
less than or equal to 100 mg per unit
View details
Q9992
SUBLOCADE- HCPCS Descriptor
- Injection, buprenorphine extended-release (sublocade), greater than 100 mg
- Manufacturer
- Indivior
- Class
- Anti-Addiction
- NDCs
- 3
greater than 100 mg per unit
View details
Q0155
Syndros- HCPCS Descriptor
- Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
- Manufacturer
- Benuvia Therapeutics
- Class
- Anti-Emetic
- NDC
- 1
0.1 mg per unit
View details
Q2053
TECARTUS- HCPCS Descriptor
- Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Gilead Sciences, Inc
- Class
- Oncology
- NDCs
- 4
up to 200 million autologous anti-cd19 car positive viable t cells per unit
View details
Q2057
TECELRA- HCPCS Descriptor
- Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Us Worldmeds
- Class
- Oncology
- NDC
- 1
per therapeutic dose per unit
View details
Q0234
Tofidence- HCPCS Descriptor
- Injection, tocilizumab-bavi, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mg
- Manufacturer
- Biogen
- Class
- COVID-19
- NDCs
- 6
1 mg per unit
View details
Q5133
TOFIDENCE- HCPCS Descriptor
- Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg
- Manufacturer
- Biogen
- Class
- Antibiotic
- NDCs
- 5
1 mg per unit
View details
Q5116
Trazimera- HCPCS Descriptor
- Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
- Manufacturer
- Pfizer
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5115
TRUXIMA- HCPCS Descriptor
- Injection, rituximab-abbs, biosimilar, (truxima), 10 mg
- Manufacturer
- Teva
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q0238
Tyenne- HCPCS Descriptor
- Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg
- Manufacturer
- Fresenius Kabi
- Class
- COVID-19
- NDCs
- 3
1 mg per unit
View details
Q5135
TYENNE- HCPCS Descriptor
- Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg
- Manufacturer
- Multiple Manufacturers
- Class
- Immunology
- NDCs
- 7
1 mg per unit
View details
Q5129
Vegzelma- HCPCS Descriptor
- Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg
- Manufacturer
- Celltrion USA
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q4074
VENTAVIS- HCPCS Descriptor
- Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
- Manufacturer
- Actelion
- Class
- Cardiology
- NDCs
- 3
up to 20 mcg per unit
View details
Q9982
VIZAMYL- HCPCS Descriptor
- Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- Manufacturer
- GE Healthcare
- Class
- Imaging/Radiopharmaceutical
- NDC
- 1
per study dose, up to 5 millicuries per unit
View details
Q5137
Wezlana- HCPCS Descriptor
- Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg
- Manufacturer
- Nuvaila
- Class
- Immunology
- NDCs
- 6
1 mg per unit
View details
Q5138
Wezlana- HCPCS Descriptor
- Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg
- Manufacturer
- Nuvaila
- Class
- Oncology
- NDC
- 1
1 mg per unit
View details
Q5155
YESAFILI- HCPCS Descriptor
- Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Ophthalmology
- NDC
- 1
1 mg per unit
View details
Q2041
YESCARTA- HCPCS Descriptor
- Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
- Manufacturer
- Kite Pharma
- Class
- Oncology
- NDC
- 1
up to 200 million car t cells per unit
View details
Q5100
YESINTEK- HCPCS Descriptor
- Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg
- Manufacturer
- Biocon Biologics Inc
- Class
- Immunology
- NDCs
- 4
1 mg per unit
View details
Q5141
YUFLYMA- HCPCS Descriptor
- Injection, adalimumab-aaty, biosimilar, 1 mg
- Manufacturer
- Celltrion USA
- Class
- Immunology: Anti-TNF
- NDCs
- 12
1 mg per unit
View details
Q5101
ZARXIO- HCPCS Descriptor
- Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
- Manufacturer
- Sandoz
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 4
1 mcg per unit
View details
Q5120
ZIEXTENZO- HCPCS Descriptor
- Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg
- Manufacturer
- Sandoz
- Class
- Oncology Colony Stimulating Factor
- NDCs
- 2
0.5 mg per unit
View details
Q5118
ZIRABEV- HCPCS Descriptor
- Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
- Manufacturer
- Pfizer
- Class
- Oncology
- NDCs
- 2
10 mg per unit
View details
Q5132
ABRILADA- HCPCS Descriptor
- Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg
- Manufacturer
- PFIZER INC.
- Class
- Immunology: Anti-TNF
- NDCs
- 4
Inactive December 31, 2024
View details
Q0222
BEBTELOVIMAB- HCPCS Descriptor
- Injection, bebtelovimab, 175 mg
- Manufacturer
- Eli Lilly and Company
- Class
- COVID-19
- NDC
- 1
Inactive December 12, 2024
View details
Q5139
BKEMV- HCPCS Descriptor
- Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg
- Manufacturer
- Amgen Inc
- Class
- Hematology
Inactive March 31, 2025
View details
Q4106
Dermagraft 2"x3" Sheet- HCPCS Descriptor
- Dermagraft, per square centimeter
- Manufacturer
- Organogenesis
- Class
- Wound Care
- NDC
- 1
Inactive December 31, 2025
View details
Q5109
IXIFI- HCPCS Descriptor
- Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg
- Manufacturer
- Pfizer
- Class
- Immunology: Anti-TNF
Inactive December 31, 2025
View details
Q0247
Sotrovimab Injection- HCPCS Descriptor
- Injection, sotrovimab, 500 mg
- Manufacturer
- GSK
- Class
- Anti-HIV
- NDC
- 1
Inactive December 12, 2024
View details
Q2017
TENIPOSIDE- HCPCS Descriptor
- Injection, teniposide, 50 mg
- Manufacturer
- WG Critical Care
- Class
- Oncology
- NDC
- 1
Inactive December 31, 2025
View details
No codes match these filters.
